Literature DB >> 23636916

Migraine prophylaxis: which drugs work and which ones don't.

Hans-Christoph Diener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23636916      PMCID： PMC3744294          DOI： 10.1007/s11606-013-2469-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  10 in total

1.  Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin.

Authors:  A Algra; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

2.  Guidelines for controlled trials of drugs in migraine: second edition.

Authors:  P Tfelt-Hansen; G Block; C Dahlöf; H C Diener; M D Ferrari; P J Goadsby; V Guidetti; B Jones; R B Lipton; H Massiou; C Meinert; G Sandrini; T Steiner; P B Winter
Journal:  Cephalalgia       Date:  2000-11       Impact factor: 6.292

3.  Going from evidence to recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Yngve Falck-Ytter; Gunn E Vist; Alessandro Liberati; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-10

4.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

Review 5.  What is "quality of evidence" and why is it important to clinicians?

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Gunn E Vist; Yngve Falck-Ytter; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-03

6.  Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.

Authors:  Stephen Silberstein; Stacey Goode-Sellers; Colleen Twomey; Jane Saiers; John Ascher
Journal:  Cephalalgia       Date:  2012-11-19       Impact factor: 6.292

7.  Efficacy of gabapentin in migraine prophylaxis.

Authors:  N T Mathew; A Rapoport; J Saper; L Magnus; J Klapper; N Ramadan; B Stacey; S Tepper
Journal:  Headache       Date:  2001-02       Impact factor: 5.887

8.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128

9.  European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Migraine-Nimodipine European Study Group (MINES).

Authors: 
Journal:  Headache       Date:  1989-11       Impact factor: 5.887

10.  European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura). Migraine-Nimodipine European Study Group (MINES).

Authors: 
Journal:  Headache       Date:  1989-11       Impact factor: 5.887
  10 in total
  1 in total

Review 1.  [Formalized consensus: clinical practice recommendations for the management of the migraine in African adult patients].

Authors:  Mahmoud Ait Kaci Ahmed; Monia Haddad; Beugré Kouassi; Hamid Ouhabi; Alain Serrie
Journal:  Pan Afr Med J       Date:  2016-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.